Symbolbild · KI-generiert
Myriad Genetics, Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Myriad Genetics is a molecular diagnostics company headquartered in Salt Lake City, Utah. It develops and markets genetic tests, in particular for risk assessment in breast and ovarian cancer (BRCA tests) as well as for psychiatric conditions. Its products are directed at physicians, hospitals and patients in the US and international healthcare markets.
Short profile generated automatically and checked for plausibility. A full editorial profile follows once we cover the company.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| Myriad Genetics, Inc. | MYGN | NASDAQ | 270 Mio. USD |
| Profound Medical Corp. | PRN | TSX | 269 Mio. USD |
| Spectral Medical Inc. | EDT | TSX | 291 Mio. USD |
| Neumora Therapeutics, Inc. | NMRA | NASDAQ | 298 Mio. USD |
| Cipher Pharmaceuticals Inc. | CPH | TSX | 305 Mio. USD |
| Organogenesis Holdings Inc. | ORGO | NASDAQ | 305 Mio. USD |
| Opus Genetics, Inc. | IRD | NASDAQ | 306 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.